Prolacta Bioscience company information, Employees & Contact Information

NICU Awareness Month Milestone: 125,000 Preemies Helped by Prolacta Bioscience's 100% Breast Milk-Based Nutrition PR Newswire

Prolacta Bioscience Neonatologist Dr. Erin Hamilton Spence Earns Breastfeeding and Lactation Medicine Certification Held by Fewer Than 100 North American Physicians PR Newswire

Prolacta's Human Milk-Based Nutrition Has Touched the Lives of 100,000 Premature and Critically Ill Infants Globally PR Newswire

Prolacta Bioscience Applauds Passage of the Maternal Health Bill in Massachusetts PR Newswire

Prolacta Bioscience Demonstrates Leadership in Human Milk Science With History of Voluntarily Reviewing Health Claims With the FDA PR Newswire

Prolacta Bioscience Applauds Passage of New York Legislation Expanding Insurance Coverage for Human Milk-Based Nutritional Products PR Newswire

Prolacta Bioscience Appoints Dr. Sandra Sullivan as Director of Clinical Education and Professional Development PR Newswire

FDA Approves First Human Milk-Based Fortifier for Term Infants to Support Growth and Recovery Following Surgery for Gastroschisis PR Newswire

Prolacta Bioscience Celebrates Prematurity Awareness Month by Recognizing Breast Milk Donors for Their Contributions to Premature Infants in the NICU PR Newswire

More Than 50% of Level III & IV NICUs in U.S. Used Prolacta's 100% Human Milk-Based Products to Help Reduce Necrotizing Enterocolitis (NEC) in the Smallest Premature Infants in 2024 PR Newswire

Prolacta Bioscience Continues Advancing the Science of Human Milk, Proud to Partner With NICU Teams in Saving Lives of Premature Infants PR Newswire

Prolacta Bioscience Develops World's First Test to Directly Detect Bacteria and Viruses, Including SARS-CoV-2, in Donor Breast Milk PR Newswire

Prolacta Bioscience Enrolls First Infant in Japan-based Clinical Trial to Evaluate the Effect of an Exclusive Human Milk Diet on Growth and Safety in Premature Infants PR Newswire

Multiple Peer-Reviewed Studies Show Prolacta's 100% Human Milk-Based Nutritional Fortifiers Reduce Risk of Life-Threatening Comorbidities in Premature Infants, Compared to Cow Milk-Based Nutrition PR Newswire

Prolacta Bioscience Approaches 20 Years Nourishing Extremely Premature Babies as #1 Hospital Provider of Human Milk-Based Fortifiers and Formulas PR Newswire

Prolacta Bioscience Appoints David Steinberg as Chief Financial Officer PR Newswire

Prolacta Bioscience Provides Update on Latest SARS-CoV-2 Data and Continued Safety of Its Human Milk-Based Nutritional Products PR Newswire

Improved Survival and Growth While Cutting Malnutrition for Premature Infants Fed Human Milk-Based Fortifiers at Sydney Hospital PR Newswire

Study: Despite Being Born Earlier and Weighing Less, Preemies Fed Prolacta's Exclusive Human Milk Diet Had Lower Motor Skill Disability Risk by Age 3 Compared to Larger Preemies Fed Cow Milk-Based Products PR Newswire

Humavant® 100% Human Milk-Based Fortifiers Helping Premature Infants in Australia Grow and Develop PR Newswire

Prolacta Bioscience Salutes World Human Milk Donation Day, Thanks Donors Who Save Fragile Infant Lives Every Day PR Newswire

Prolacta Bioscience Introduces Its First Evidence-Based Feeding Protocol for an Exclusive Human Milk Diet in the NICU PR Newswire

Prolacta Bioscience Recognizes Nurses Caring for Fragile Infants Every Day Throughout Neonatal Nurses Week and NICU Awareness Month PR Newswire

Prolacta Bioscience Applauds Ohio Legislature For Supporting Medicaid Reimbursement For Donor Human Milk-Derived Products PR Newswire

Prolacta Bioscience® Launches Easier-to-Read Labels for its Human Milk-Based Neonatal Nutritional Products PR Newswire

Prolacta Bioscience Appoints Dr. Erin Hamilton Spence as Director of Clinical Education and Professional Development PR Newswire

Preterm Infant Study Finds Proactive Use of Prolact CR® Cream Improves Growth and Reduces NICU Costs PR Newswire

Hot Topics in Neonatology® 2024 Conference to Feature Symposium on Clinical Impact & Cost Savings of an Exclusive Human Milk Diet PR Newswire

Prolacta Bioscience® Supports Prematurity Awareness Month with New Educational Resources for Parents of Preemies PR Newswire

Study Shows Vat Pasteurization Outperforms Other Methods in Preserving Human Milk's Native Bioactive Properties East Oregonian

Prolacta’s 100% Human Milk-Based Fortifiers Lower the Risk GlobeNewswire

Prolacta Starts Drug Development Los Angeles Business Journal

New Peer-Reviewed Study Finds Vat Pasteurization Retains Molecular Structure of Naturally Occurring Bioactive Proteins in Human Donor Milk, Similar to Raw Breast Milk PR Newswire

Prolacta Bioscience Begins Testing Its Breast Milk-Based Products for Use in Japan Los Angeles Business Journal

First for Japan: Prolacta Bioscience’s human milk-based fortifiers approved for clinical trial on premature infants NutraIngredients.com

Prolacta develops niche delivering breast milk to hospitals Los Angeles Times

Preemies benefit from breast milk donor program Wichita Eagle

Donor milk benefits preemies The Tuscaloosa News

Prolacta Bioscience Raises $9 Million Los Angeles Business Journal

Got (breast) milk? Piedmont Healthcare is taking donations Atlanta Magazine

Going For $1 An Ounce: The Burgeoning Trade In Mothers’ Milk KFF Health News

New breast milk bank for Delaware moms The News Journal